Ischemia-modified albumin as an oxidative stress marker in preeclampsia
dc.authorid | Alanbay, Ibrahim/0000-0002-5511-6938 | |
dc.authorid | Engin-Ustun, Yaprak/0000-0002-1011-3848 | |
dc.authorwosid | Üstün, Yusuf/AAC-2674-2020 | |
dc.authorwosid | Ustun, Yaprak/KFQ-9767-2024 | |
dc.authorwosid | Alanbay, Ibrahim/A-3349-2017 | |
dc.contributor.author | Ustun, Yusuf | |
dc.contributor.author | Engin-Ustun, Yaprak | |
dc.contributor.author | Ozturk, Ozlem | |
dc.contributor.author | Alanbay, Ibrahim | |
dc.contributor.author | Yaman, Halil | |
dc.date.accessioned | 2024-08-04T20:32:42Z | |
dc.date.available | 2024-08-04T20:32:42Z | |
dc.date.issued | 2011 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Methods. aEuro integral Serum ischaemia-modified albumin levels were measured in 18 normotensive and 36 preeclamptic pregnant women by enzyme linked immuno-sorbent assay. Patients were subdivided as having either mild (n == 18) or severe preeclampsia (n == 18). Receiver operating characteristic curve was constructed, and sensitivity and specificity were calculated based on the best cut-off. Results. aEuro integral IMA levels were significantly higher in the mild and severe preeclamptic groups than in the control group. IMA with a cut-off point of 0.31 identified women with preeclampsia with sensitivity 80%% and specificity 77.8%%. Conclusion. aEuro integral Our study demonstrates that serum levels of IMA correlate with severity of preeclampsia. | en_US |
dc.identifier.doi | 10.3109/14767058.2010.497879 | |
dc.identifier.endpage | 421 | en_US |
dc.identifier.issn | 1476-7058 | |
dc.identifier.issn | 1476-4954 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 20617896 | en_US |
dc.identifier.scopus | 2-s2.0-79751478215 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 418 | en_US |
dc.identifier.uri | https://doi.org/10.3109/14767058.2010.497879 | |
dc.identifier.uri | https://hdl.handle.net/11616/95251 | |
dc.identifier.volume | 24 | en_US |
dc.identifier.wos | WOS:000286993000006 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Journal of Maternal-Fetal & Neonatal Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Preeclampsia | en_US |
dc.subject | ischaemia-modified albumin | en_US |
dc.title | Ischemia-modified albumin as an oxidative stress marker in preeclampsia | en_US |
dc.type | Article | en_US |